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Abstract
Small RhoGTPases regulate changes in post-synaptic spine morphology and density that
support learning and memory. They are also major targets of synaptic disorders, including
Autism. Here we sought to determine whether upstream RhoGTPase regulators, including
GEFs, GAPs, and GDIs, sculpt specific stages of synaptic development. The majority of
examined molecules uniquely regulate either early spine precursor formation or later matura-
tion. Specifically, an activator of actin polymerization, the Rac1 GEF β-PIX, drives spine pre-
cursor formation, whereas both FRABIN, a Cdc42 GEF, and OLIGOPHRENIN-1, a RhoA
GAP, regulate spine precursor elongation. However, in later development, a novel Rac1
GAP, ARHGAP23, and RhoGDIs inactivate actomyosin dynamics to stabilize mature synap-
ses. Our observations demonstrate that specific combinations of RhoGTPase regulatory pro-
teins temporally balance RhoGTPase activity during post-synaptic spine development.
Introduction
RhoGTPases are molecular switches that orchestrate various signaling pathways and are
best known for being master regulators of actin cytoskeleton polymerization and organization
[1]. Recently, they have emerged as crucial regulators of neuronal development, including
dendritic arborization, growth cone development, axon guidance, and post-synaptic spine
morphogenesis underlying excitatory neurotransmission [2–4]. During normal synaptic devel-
opment, the small RhoGTPase, Rac1, promotes the formation of filopodia-like spine precur-
sors [5–8] that subsequently mature through RhoA/ROCK-dependent myosin II activation
into polarized mushroom-shape spines [9,10]. Further excitatory stimulation associated with
long-term potentiation leads to Rac1-driven spine head expansion [6,11].
Through these mechanisms RhoGTPases also impact learning and memory. Altered
RhoGTPase signaling leads to abnormal spine morphology and synaptic development and
appears to contribute to the pathology of neuronal disorders, such as Autism Spectrum Disor-
ders and non-syndromic mental retardation, as well as neurodegenerative disorders, like Alz-
heimer’s disease (AD) [12–16].
RhoGTPases are activated by Guanine Exchange Factors (GEFs) and inactivated by
GTPase-Activating Proteins (GAPs), while Guanine Dissociation Inhibitors (GDIs) attenuate
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RhoGTPase signaling by binding and sequestering the inactive GDP-bound state in the cytosol
[17]. Several of these upstream RhoGTPase regulatory proteins are implicated in neurodeve-
lopmental disorders. For example, mutations in the RhoA-GAP OLIGOPHRENIN-1 result in
non-syndromic mental retardation [16], through glutamatergic dysfunction, preventing den-
dritic spine development and synapse maturation [15,18]. Furthermore, RhoGTPases are
disproportionately represented in copy number variants associated with Autism and schizo-
phrenia, further highlighting the fundamental developmental role of RhoGTPases in shaping
proper neuronal connections [19,20].
Despite a fundamental role for RhoGTPase signaling in neurons, how and when these
signaling pathways are activated is not known. In this present study, we explored whether
RhoGTPase regulators exhibit stage-specific roles in synaptic development. Our results suggest
that RhoGTPase regulators function temporally at discrete stages of synaptic development.
Individual regulators orchestrate actomyosin dynamics that support post-synaptic spine mor-
phogenesis in either early spine precursor formation or later spine maturation. In addition to
demonstrating that specific molecules uniquely remodel synaptic architecture at distinct devel-
opmental periods, this study also suggests the feasibility of targeted therapeutic intervention of
actomyosin regulation during synaptic plasticity.
Results
Expression of synaptic RhoGTPase regulatory proteins in neuronal
development
While previous studies have largely focused on a particular stage of synaptic development, we
sought to determine how RhoGTPase regulators function throughout synaptic development
by evaluating their contribution to both early development, when immature filopodia-like
spine precursors form, and later synapse formation, when spines mature into a mushroom-
shaped morphology. These stages of synapse development are observed in vitro with cultured
rat hippocampal neurons; they exhibit robust spine precursor formation at approximately 1
week in culture and spine maturation after 2–3 weeks in culture (Fig 1A) [9,21,22]. We used
shRNA to acutely downregulate expression of select RhoGTPase regulators at these distinct
stages of synaptic development (S1 Fig). We selected known synaptic RhoGTPase regulatory
proteins, β-PIX, a GEF [5,23,24], and OLIGOPHRENIN-1, a GAP protein that is mutated in
non-syndromic mental retardation [15,18]. We also included the three mammalian RhoGDI
family members (α, β, and γ)[25], to develop a broader and more holistic picture of RhoGT-
Pase regulation during synaptic development. All of these RhoGTPase regulators are either
mutated or have copy number variants associated with known synaptic disorders, including
non-syndromic mental retardation and Autism Spectrum Disorders (ASD) (Table 1), although
their specific contribution to disease pathology may not yet be determined. As a negative con-
trol for excitatory synapse development associated with spines, we included ARHGEF9, a reg-
ulator of gephyrin clustering and inhibitory synapse formation [26,27].
We also identified and included potential novel regulators of synaptic RhoGTPase activity
by screening published synaptic proteomes [28–32] for targets containing either the RhoGAP
domain or possessing GEF characteristics, e.g., a Dbl Homology (DH) domain followed by the
Pleckstrin Homology (PH) domain [33]. This search revealed potential RhoGTPase regulatory
proteins whose role in synaptic development is understudied or completely unknown. These
include the GEFs, FRABIN/FGD4 and VAV2, as well as a GAP, ARHGAP23 (Table 1).
Using Real-Time RT-PCR, we assayed for mRNA expression in primary rat hippocampal
neurons cultured for either 1 or 2 weeks (Fig 1B). Rat hippocampal neurons express all of the
selected RhoGTPase regulators, except for RhoGDI-β, which is predominantly found in
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Fig 1. Expression of RhoGTPase regulators during synapse development. A) Primary rat hippocampal neurons expressing
GFP were stained for the dendritic marker, MAP-2 (MAP-2). At ~1 week in culture (days in vitro, DIV-10), filopodia-like spine
precursors extend from the dendritic shaft. However, after 2 weeks, spines begin to mature into a polarized mushroom-shape,
characterized by a bulbous spine head atop a thin spine neck. B) Real-Time RT-PCR of RhoGTPase regulators from RNA harvested
from primary rat hippocampal neurons grown for either 1 or 2 weeks in culture (DIV-7, grey bars; DIV-14, black bars). RNA expression
levels are expressed as a percentage of actin RNA. (n 5 neuron cultures for each time point; p<0.001 for Arhgdia expression at
DIV-7 vs DIV-14 (Mann-Whitney Rank Sum Test) and p = 0.033 for Arhgdig expression at DIV-7 vs DIV-14 (t-test); RNA expression
levels of all other regulators was not statistically significant between DIV-7 and DIV-14.
doi:10.1371/journal.pone.0170464.g001
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Table 1. Synaptic Regulators of RhoGTPase Signaling.
RhoGTPase Target Proteome
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hematopoietic cells [34], and was therefore incorporated as an additional negative control.
Strikingly, the Rac1 GEF, β-PIX, exhibited the highest levels of expression at both time points.
However, only Rho GDI-α ανδ-γ significantly increased during neuronal maturation, suggest-
ing a specific role for RhoGDIs in synapse maturation.
The Rac1 GEF, β-PIX, drives spine precursor formation
To assess the role of specific GEFs and GAPs in spine precursor formation and elongation during
early stages of neuronal development, we performed acute shRNA knockdowns at approximately
1 week in culture (DIV6/7) and assessed spine morphology and density after 72 hours (DIV9/
10). At one week in development, control neurons exhibit an abundance of immature filopodia-
like spine precursors with very few mature spines (Fig 1A). These immature spine precursors are
highly dynamic, allowing them to contact a pre-synaptic partner [9,22,35]. We therefore hypoth-
esized that decreased expression of activators of actin polymerization, such as the Rac1 GEF,
β-PIX, would reduce both spine precursor density and length. In support of this hypothesis,
shRNA sequences targeting β-Pix decreased the density of spine precursors (Fig 2A and 2B).
By contrast, we did not observe consistent, significant changes in spine density with
shRNAs against the other GEFs or GAPs identified in Table 1 (data not shown). This is consis-
tent with a role for Rac1 in the formation of immature filopodia-like spine precursors [5–8].
We confirmed this role for Rac1 in the formation of filopodia-like spine precursors using a
genetically encoded photoactivatable Rac1 (PA-Rac) [36], which increased formation of spine
precursors along the dendritic shaft after acute photoactivation (Fig 3A and 3C and S1 Video).
Unexpectedly, shRNAs against β-Pix did not decrease spine length, but resulted in increased
length (Fig 2A and 2C), similar to expression of dominant negative Rac1T17N [6]. Consistent
with this finding, while chronic Rac1 activation increased spine length (Fig 3B and 3C ‘Lit’
Rac) acute Rac1 photoactivation did not alter spine length (Fig 3B and 3C PA-Rac). Together,
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Balanced RhoA and Cdc42 activities regulate spine precursor elongation
By contrast, shRNAs against the RhoA GAP, Oligophrenin-1, decreased spine length (Fig 2A
and 2C) as previously described for spines in the CA1 region of rat hippocampal slices [18].
Though primarily known for its role in myelination and Charcot-Marie Tooth Disease [37,38],
shRNAs against the CDC42 GEF, Frabin, also decreased spine length (Fig 2A and 2C). We did
not observe consistent, significant changes in spine precursor length with shRNAs against the
other GEFs or GAPs identified in Table 1 (data not shown). These results lead us hypothesize
that competition between RhoA-driven myosin II contractility and Cdc42-mediated actin
polymerization may regulate spine precursor elongation.
To test whether Cdc42 activity is negatively regulated by myosin II-mediated contractility,
we measured Cdc42 activity in spine precursors using a FRET biosensor, Raichu-Cdc42 [39],
following treatment with the non-muscle myosin II (NMII) inhibitor, blebbistatin. Consistent
with previous results, NMII inhibition resulted in spine elongation [9,40]. Increased Cdc42
Fig 2. Regulators of spine precursor formation and elongation. A) Representative Images of GFP-expressing DIV-9 neurons transfected with the
indicated shRNA targeting sequence for 72 hours. B) β-pix shRNA targeting sequences significantly decrease spine precursor density in DIV-9/10 neurons.
Spine density is expressed as the percentage of the average control spine density. n = 24 control neurons, 15 β-PIX shRNA #1 neurons, and 7 β-PIX shRNA
#2 neurons; p = 0.001 for Control vs β-pix shRNA #1 (t-test) and p = 0.007 for Control vs β-pix shRNA #2 (t-test). C) Cumulative distribution plot of spine length
in DIV-9/10 primary rat hippocampal neurons co-expressing GFP and the indicated shRNA targeting sequence. Spine length is expressed as a percentage of
the average control spine length. shRNAs against either the RhoA-GAP, Oligophrenin-1, or Cdc42-GEF, Frabin, significantly decrease spine length, whereas
shRNAs against β-pix significantly increase spine length. n = 1114 control, 680 Oligophrenin-1 shRNA #1, 115 Oligophrenin-1 shRNA #2, 613 Frabin shRNA
#1, 393 Frabin shRNA #2, 465 β-pix shRNA #1, and 166 β-pix shRNA #2 spines; p = 0.005 for Control vs β-pix shRNA #1 (Mann-Whitney Rank Sum Test),
p < 0.001 for Control vs β-pix shRNA #2 (Mann-Whitney Rank Sum Test), p = 0.001 for Control vs Frabin shRNA #1 (Mann-Whitney Rank Sum Test), p = 0.01
for Control vs Frabin shRNA #2 (Mann-Whitney Rank Sum Test), p < 0.001 for Control vs Oligophrenin-1 shRNA #1 (Mann-Whitney Rank Sum Test),
p < 0.001 for Control vs Oligophrenin-1 shRNA #2 (Mann-Whitney Rank Sum Test).
doi:10.1371/journal.pone.0170464.g002
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activity accompanied the spine elongation (Fig 3D), thus confirming that NMII negatively reg-
ulates Cdc42-mediated elongation to determine spine precursor length.
ARHGAP23 promotes spine maturation
While actin polymerization drives spine precursor formation, RhoA/ROCK-mediated myosin
II activation is necessary for spine maturation into a polarized mushroom-shape [9,10,41].
Furthermore, RhoA and Rac1 mutually inhibit each other’s activity [42], even at synapses [10],
leading us to hypothesize that spine maturation might be regulated by either activation of
RhoA and/or inactivation of Rac1. To assess this, we performed acute shRNA knockdowns of
specific regulators after 2 weeks in culture (DIV14) and assessed spine morphology and den-
sity after 48 hours (DIV16) (Fig 4). Regulators of spine precursor formation, including acti-
vators of actin polymerization, β-PIX and FRABIN, and OLIGROPHENIN-1, a GAP that
inactivates RhoA-driven NMII activation, did not affect spine length or density during spine
maturation (Fig 4A, 4B and 4D). Interestingly, shRNAs against the GEF, Vav2, consistently
resulted in increased spine length (Fig 4A and 4E). However, we observed the most prominent
effect on mature spine morphology and density with shRNAs toward Arhgap23, a putative
GAP identified by our in-silico screen. shRNAs against Arhgap23 increased spine density and
resulted in immature spine morphologies with increased spine length similar to filopodia-like
spine precursors (Fig 4A, 4C and 4E), leading us to hypothesize that ARHGAP23 may function
to inactivate Rac-driven actin polymerization.
ARHGAP23 is a novel Rac1 GAP
ARHGAP23 is a novel RhoGTPase regulator identified in silico [43], but its cellular function is
unknown. To determine whether it indeed functions as a Rac1 GAP, we used migratory CHO.
K1 cells to readily visualize the effects of shRNA downregulation or expression on actin fila-
ment bundle organization and adhesion maturation, properties regulated by RhoGTPases. In
migratory cells, Rac1-mediated actin polymerization contributes to the formation of the lead-
ing edge [17]. Similar to neurons, CHO.K1 cells also express ARHGAP23 (data not shown).
ARHGAP23 knockdown resulted in extensive lamellipodia formation and nascent adhesions
(Fig 5C and 5D). Conversely, cells expressing GFP-tagged ARHGAP23 exhibited increased
adhesion maturation (Fig 5A and 5B, compare adhesions in control cells of S2 Video with
adhesion maturation in a GAP23-GFP-expressing CHO.K1 cells in S3 Video). These results
are consistent with a corresponding increase in RhoA-mediated actomyosin bundle formation
in response to Rac1 inactivation [1,44,45]. A Rac FRET biosensor [39] confirmed that shRNA
against ARHGAP23 increased Rac1 activity to levels indistinguishable from constitutively
active Raichu Rac V12 (Fig 5D and 5E), demonstrating that ARHGAP23 functions as a novel
Rac1 GAP in adhesion maturation of migratory CHO.K1 cells as well as synapse maturation in
neurons.
GDI-mediated attenuation of RhoGTPase signaling maintains the
mature mushroom-shape spine
We next investigated the role of the three mammalian GDI isoforms (α, β, and γ) in spine
development [25]. Expression of both α and γ significantly increases during neuronal matura-
tion as measured by real-time RT-PCR, while β exhibited negligible RNA expression during
both early (DIV7) and later (DIV14) neuronal development (Fig 1B). Consistent with these
RNA expression profiles, knockdown of either GDI-α or -γ, but not β, during neuronal matu-
ration resulted in a striking reversion to immature filopodia-like spine precursors (Fig 6),
demonstrating that attenuation of RhoGTPase signaling is necessary for the maintenance of
RhoGTPase Regulators in Synaptic Development
PLOS ONE | DOI:10.1371/journal.pone.0170464 January 23, 2017 7 / 21
Fig 3. Rac drives spine precursor formation, while myosin-II and Cdc42 activity regulate spine length. A) Rac1 photoactivation
increases spine precursor formation. DIV14-21 primary rat hippocampal neurons expressing either photoactivatable Rac1 or as a positive
control, constitutively activated Rac1 (‘Lit’ PA-Rac), were kept in dark (black bars) or exposed to room lighting for 10min (white bars). The
resulting spine density is expressed as percent control unactivated PA-Rac-expressing neurons. n = 24 PA-Rac neurons kept in dark, 23
PA-Rac light-exposed neurons, 8 ‘lit’ PA-Rac neurons kept in dark, and 9 ‘lit’ PA-Rac light-exposed neurons; p = 0.047 PA-Rac dark vs
light-acivated (t-test). B) Acute Rac1 photoactivation does not affect spine length, unlike constitutive Rac1 activity (‘Lit’ control). C)
RhoGTPase Regulators in Synaptic Development
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mature-mushroom-shaped spines, and is the first evidence of a role for GDIs in post-synaptic
spine plasticity.
Discussion
Our research demonstrates that unique combinations of Rho GTPase family members regulate
distinct stages of synaptic development. Altered spine formation and maturation are increas-
ingly implicated in neurodevelopmental disease pathology, whereas the maintenance of
mature synaptic connections is lost in neurodegenerative disease pathology. In addition, regu-
latory pathways of the actin cytoskeleton are increasingly implicated in these neuronal disor-
ders. Despite this association, how synaptic connections are temporally constructed and
maintained has been unclear.
We showed that distinct RhoGTPase regulators sequentially orchestrate synapse formation
and maturation. During spine formation, the Rac1 GEF β-PIX promoted spine precursor for-
mation, while the RhoA GAP OLIGOPHRENIN-1 and Cdc42 GEF FRABIN cooperatively
regulated spine precursor elongation. These results lead us to hypothesize that Rac1 initiates
spine precursor formation, while competition between RhoA-mediated myosin II activation
and Cdc42-driven actin polymerization determines spine length. In support of this hypothesis,
acute Rac1 photoactivation drove spine precursor formation, but did not affect spine length.
By comparison, myosin II inhibition promoted Cdc42 activation together with increased spine
length. How can we understand these differential roles for Rac1 and Cdc42-mediated actin
polymerization on spine precursor formation and subsequent elongation? In general, Rac1
drives Arp2/3-mediated branched actin arrays, generating lamellipodia-like veils along the
dendritic shafts of neurons [8,10,46]. Intriguingly, EM of filopodia-like spine precursors sug-
gests that they emanate from patches of branched actin [47] consistent with a role for Rac1 in
the initiation of spine precursor formation. In contrast to these branched actin structures,
Cdc42 promotes linear actin polymerization, generating filopodia in migratory cells, though
the role for Cdc42 in synaptic plasticity and filopodia-like spine precursors is less clear. Here
we show that, while not required for spine precursor formation, FRABIN-mediated Cdc42
activation drives spine precursor elongation. This spine autonomous role for Cdc42 is con-
sistent with recent evidence for spine- restricted Cdc42 activity in response to glutamate-
mediated stimulation [48]. However, active Rac and RhoA spread through the dendrite into
adjacent spines [48], suggesting either differential diffusion properties of RhoGTPases them-
selves or association of upstream regulators with distinct synaptic signaling scaffolds.
In contrast to spine formation, spine maturation was characterized by Rac1 inactivation via
the novel RhoGTPase regulator, ARHGAP23. RhoGDI-mediated attenuation of RhoGTPase
signaling pathways and subsequent actomyosin dynamics was also necessary for the mainte-
nance of mature spines. These studies support a model for spine development whereby the
switch from GEF-mediated Rac1/Cdc42 activation to GAP/GDI-mediated Rac1/RhoGTPase
inactivation promotes spine maturation and the maintenance of excitatory synaptic con-
nections. This Rac1 activity switch is consistent with previous work demonstrating that an-
tagonism between the Rac1 GEF, TIAM1, and Rac1 GAP, BCR, control spine and synapse
development [49]. Similarly, the Rac1 GEF, kalirin-7, is known to have reduced GEF activity
Representative images of neurons expressing either photoactivable Rac1 (PA-Rac1, top panel) or the constitutively active ‘lit’ Rac1 control
(bottom panel) that were either kept in the dark (left panel) or exposed to room lighting for 10 min (light-activated, right panel). D) DIV-9/10
primary rat hippocampal neurons transfected with WT Raichu Cdc42 were treated with 50μM Blebbistatin for 1 hour or left untreated.
FRET was calculated as the ratio of FRET signal to CFP donor signal. Blebbistatin treatment increases Cdc42 activity by ~7%. n = 50
spine precursors each for untreated and Blebbistatin-treated, p = 0.016 (t-test).
doi:10.1371/journal.pone.0170464.g003
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when associated with the post-synaptic density [50], suggesting that maintenance of mature
synapses involves Rac1 inactivation.
However, subsequent Rac1 and Cdc42 activation is necessary for spine head enlargement
following excitatory neurotransmission [11,48]. Thus, it will be important to understand the
mechanisms that transiently promote Rac1 and Cdc42 activity in response to excitatory
Fig 4. Regulators of spine maturation are distinct from regulators of spine precursor formation. A) Representative Images of GFP-expressing
DIV-16 neurons transfected with the indicated shRNA targeting sequence for 48 hours. B) Regulators of spine precursor formation, OLIGOPHRENIN-1
(OPHN-1), β-PIX, and FRABIN, do not alter spine density later in synaptic development (DIV-16). Spine density is expressed as the percentage of the
average control spine density. n = 44 control, 16 Ophn-1 shRNA #1, 5 Ophn-1 shRNA #2, 17 β-pix shRNA #1, 7 β-pix shRNA #2, 15 Frabin shRNA #1, 8
Frabin shRNA #2 neurons (Spine density was not significantly different from control as determined by t-test, except for β-pix shRNA #1 which was determined
by Mann-Whitney Rank Sum Test). C) Arhgap23 shRNAs significantly increase spine density later during synaptic development (DIV-16). n = 44 control
(same as B), 22 Arhgap23 shRNA #1, and 12 Arhgap23 shRNA #2 neurons; p = 0.02 for Control vs Arhgap23 shRNA #1 (Mann-Whitney Rank Sum Test),
p = 0.002 for Control vs Arhgap23 shRNA #2 (Mann-Whitney Rank Sum Test). D) Regulators of spine precursor formation, OLIGOPHRENIN-1 (OPHN-1),
β-PIX, and FRABIN, do not alter spine length later in synaptic development (DIV-16) neurons. Cumulative distribution plot of spine length in DIV-16 primary rat
hippocampal neurons co-expressing GFP and the indicated shRNA targeting sequence. Spine length is expressed as a percentage of the average control
spine length. n = 3273 control, 651 Ophn-1 shRNA #1, 130 Ophn-1 shRNA #2, 729 β-pix shRNA #1, 449 β-pix shRNA #2, 556 Frabin shRNA #1, 688 Frabin
shRNA #2 spines (Spine length was not significantly different from control as determined by Mann-Whitney Rank Sum test). E) Arhgap23 and Vav2 shRNAs
significantly increase spine length later in neuronal development (DIV-16). n = 3273 control (same as D), 1207 Arhgap23 shRNA #1, 1182 Arhgap23 shRNA
#2, 962 Vav2 shRNA #1, and 551 Vav2 shRNA #2 spines; p < 0.001 for Control vs Arhgap23 shRNA #1 (Mann-Whitney Rank Sum Test), p < 0.001 for Control
vs Arhgap23 shRNA #2 (Mann-Whitney Rank Sum Test), p = 0.006 for Control vs Vav2 shRNA #1 (Mann-Whitney Rank Sum Test), p < 0.001 for Control vs
Vav2 shRNA #2 (Mann-Whitney Rank Sum Test).
doi:10.1371/journal.pone.0170464.g004
RhoGTPase Regulators in Synaptic Development
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Fig 5. ARHGAP23 is a novel Rac GAP that regulates adhesion maturation. A) Representative images of ARHGAP23-GFP or
GFP control CHO.K1 cells plated on fibronectin and stained for the adhesion marker, paxillin, and actin filaments (rhodamine
phalloidin). B) Quantification of ARHGAP23 puncta size (n = 44 cells) in ARHGAP23 GFP-expressing CHO.K1 cells and paxillin
puncta size in either ARHGAP23 GFP-expressing CHO.K1 cells (n = 35 cells) or control CHO.K1 cells (n = 12 cells); p = 0.015 for
GAP23 vs paxillin puncta size in GAP23 GFP-expressing CHO.K1 cells (Mann-Whitney Rank Sum Test), p = 0.012 for paxillin
puncta size in GAP23 GFP-expressing vs control CHO.K1 cells (Mann-Whitney Rank Sum Test). C) Representative images of CHO.
K1 cells transfected with GFP and either control empty pSUPER vector or ARHGAP23 shRNA and plated on fibronectin. Cells were
stained for the adhesion marker, paxillin, and actin filaments (rhodamine phalloidin). D) Quantification of adhesion size in control
(n = 24 cells) or Arhgap23 shRNA (n = 25 cells) CHO.K1 cells; p = 0.006 (Mann-Whitney Rank Sum Test). E) Ratiometric FRET
images of control or Arhgap23 shRNA CHO.K1 cells co-transfected with the WT Raichu Rac FRET probe or constitutively active
control, Raichu Rac V12, and plated on fibronectin. The top panel shows the intensity of the CFP donor of the FRET probe in each
cell. F) Quantification of FRET intensity in control or Arhgap23 shRNA cells expressing Raichu Rac probes. n = 31 control WT
RhoGTPase Regulators in Synaptic Development
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stimulation, leading to synaptic strengthening. Consistent with the role of Rac1 and Cdc42 in
synaptic strengthening, chronic Rac1 or Cdc42 inactivation with dominant negative constructs
reduces spine maturation [51]. Additionally, the Rac1 GAP, ARHGAP12, negatively regulates
spine volume [52], supporting the hypothesis that specific RhoGTPase regulators orchestrate
distinct stages of synaptic development and plasticity. Finally, glutamate uncaging leads to
Raichu Rac, 24 control Raichu Rac V12, 11 Arhgap23 shRNA #1 WT Raichu Rac cells, 7 Arhgap23 shRNA #1 Raichu Rac V12
cells, 18 Arhgap23 shRNA #2 WT Raichu Rac cells, 13 Arhgap23 shRNA #2 Raichu Rac V12 CHO.K1 cells; p < 0.001 for WT
Raichu Rac vs Raichu Rac V12 in control CHO.K1 cells (t-test), but WT Raichu Rac is not statistically different from Raichu Rac V12
when CHO.K1 cells are transfected with either Arhgap23 shRNA sequence (t-test).
doi:10.1371/journal.pone.0170464.g005
Fig 6. A & B) RhoGDIα and γmaintain spine maturation. Quantification of Spine Length in GFP-
expressing DIV16-27 neurons transfected with the indicated shRNA targeting sequences or control neurons.
Spine Length is normalized to the average control spine length for each neuronal culture. n = 1232 control
spines, 1757 Arhgdi-α shRNA spines, 1305 Arhgdi-β shRNA spines, and 1526 Arhgdi-γ shRNA spines;
p < 0.001 for control neurons vs either Arhgdi-α shRNA or Arhgdi-γ shRNA neurons, but is not statistically
different from Arhgdi-β shRNA neurons (Mann-Whitney Rank Sum Test).
doi:10.1371/journal.pone.0170464.g006
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coincident activation of RhoA, Rac, and Cdc42 [48], suggesting that the GDI-mediated attenu-
ation of RhoGTPase activity must also be transiently and dynamically regulated in response to
excitatory stimulation to allow for structural synaptic plasticity. Thus, it will be of interest to
perform a future screen with acute knockdown followed by NMDA receptor activation to
assess the role of specific RhoGTPase regulators in response to excitatory stimulation leading
to synaptic strengthening. Ultimately, our identification of distinct RhoGTPase regulators for
particular stages of synaptic development suggests the feasibility of targeted intervention of
actomyosin dynamics during critical periods of neuronal development.
Materials and Methods
Antibodies and reagents
A mouse monoclonal antibody (MAB378) against the dendritic marker, MAP-2, was pur-
chased from Millipore. A mouse monoclonal antibody against paxillin (Clone 349) was pur-
chased from BD Biosciences. Alexa-conjugated secondary antibodies were from Invitrogen.
Rhodamine phalloidin was purchased from Cytoskeleton (Denver, CO) and used at a ratio of
1:100. Blebbistatin, was purchased from Calbiochem (La Jolla, CA) and used at a concentration
of 50 μM.
Neuronal culture and transfection
Low-density hippocampal cultures were prepared from E19 rat embryos as described previ-
ously [57]. All experiments were carried out in compliance with the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health and approved by the University
of Virginia Animal Care and Use Committee (Protocol Number: 2884). Neurons were plated
on glass coverslips coated with 1 mg/ml poly-L-lysine at an approximate density of 70 cells/
mm2 and were transfected at DIV-6/7 using a modified calcium phosphate precipitation
method as described previously [57] or at DIV-14 with Lipofectamine 2000 (Life Technolo-
gies) used at a ratio of 1.3 μl lipofectamine 2000 per 1 μg DNA. shRNAs were co-transfected
with GFP. Neurons were fixed and stained 48–72 hours after transfection.
Plasmids and shRNA sequences
Target small hairpin RNA (shRNA) sequences used in this study were cloned into a pSuper
vector (Oliogoengine) between the BamHI and HindIII restriction sites.
Arhgap23 shRNA #1: 5´-CATCGAGGCCAATCGGATA-3´
Arhgap23 shRNA #2: 5´-CCGCAGAGGATCATCGTGA-3’
Arhgdia shRNA #1: 5’-GGTGTGGAGTACCGGATAA-3’
Arhgdib shRNA #1: 5’-GCTAAAGGAAGGTATCGAA-3’
Arhgdig shRNA: 5’-ACGAGGTGCTGGACGAAAT-3’
Arhgef7 (β-pix) shRNA #1: 5’-CAACAGGACTTGCACGAAT-3’
Arhgef7 (β-pix) shRNA #2: 5’-GGAGCATGATCGAGCGCAT-3’
Arhgef9 shRNA #1: 5’-CAACAAGGAAACCGAAGAA-3’
Arhgef9 shRNA #2: 5’-ACATAGACCTTTACGTATA-3’
Frabin shRNA #1: 5’-CCAAGATGGATACGTGATA-3’
Frabin shRNA #2: 5’–GTAAATATCCCCAGCGGTA-3’
Oligophrenin-1 shRNA #1: 5’-TGAGATTAATATTGCGGAA-3’
Oligophrenin-1 shRNA #1: 5’-CCAGTCGTTTCAGTTTGAT-3’
Vav2 shRNA #1: 5’-GGTGGAAGGGCGAGACGAA-3’
Vav2 shRNA #2: 5’-CCCAGTTCCTGTGTCTGAA-3’
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Full-length human Arhgap23 was obtained from Dharmacon ORFeome library and sub-
cloned into the pEGFP-N1 vector (Clonetech). FRET biosensor probes, including Raichu Rac
Cdc42 and WT Raichu Rac and constitutively active, Raichu Rac G12V (V12), were kindly
provided by M. Matsuda (Osaka University, Osaka, Japan) [39], and consist of YFP, the CRIB
domain of human PAK1 (amino acids 68–150), human Cdc42 or Rac1 (amino acids 1–176)
and CFP cloned into a derivative of the pCAGGS vector [91]. The genetically encoded photo-
activatable Rac was kindly provided by Dr. Klaus Hahn (UNC Chapel Hill, NC, USA) [36],
and was activated by exposure to room lighting for 10min (Fig 1C) or acute activation with
458nm light for approximately 1 min using confocal imaging as described below. Full-length
chicken paxillin-GFP cloned into the pEGFP-N3 vector (Clontech) has been described previ-
ously [92] and GFP was replaced by mCherry from R. Tsien (University of San Diego, San
Diego, CA) [93].
Immunocytochemistry
Neurons and CHO.K1 cells were fixed in 4% formaldehyde ultra-pure EM grade (Polysciences,
Inc., Warrington, PA) + 4% sucrose in PBS for 20 min at room temperature and permeabilized
with 0.2% Triton X-100 for 5–10 min at room temperature, followed by blocking and antibody
incubations in 5–20% normal goat serum (Abcam). Coverslips were mounted with Vectashield
mounting media (Vector Laboratories, Burlingame, CA).
CHO.K1 cell culture and transfection
Wild-type CHO.K1 fibroblast were cultured in low glucose DMEM (Invitrogen/Life Technol-
ogy, Invitrogen) supplemented with nonessential amino acids, 100 units/ml penicillin, 100 μg/
ml streptomycin, and 10% FBS. Co-transfections of Raichu-Rac FRET probes and plasmids
containing the ArhGAP23 shRNAs were perform using Lipofectamine 2000 (Invitrogen) at a
ratio of 5 μl lipofectamine per 1 μg DNA. After 48–72 hours, 1X104-2x104 cells were plated for
2–4 hours on glass bottom dishes, which were coated with 2-μg/ml fibronectin. For FRET,
cells were either imaged live or fixed by incubation for 15–20 minutes at RT with a 4% parafor-
maldehyde + 4% sucrose PBS solution and imaged in PBS.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from cells with TRIZOL (Invitrogen). Total RNA was reverse tran-
scribed using the iScript CDNA Synthesis Kit (BioRad). qRT-PCR assays were performed
using TaqMan Gene Expression Assays (Applied Biosystems) according to manufacturer´s
protocol. The following FAM-MGB TaqMan probes (Applied Biosystems/ThermoFisher)
were used to analyze expression of rat RhoGTPase regulators during neuronal development:
Rat Actb (Rn00667869_m1); Rat Arhgap23 (Rn01496413_m1); Rat Arhgdia (Rn01751927_g1);
Rat Arhgdib (Rn01459333_m1); Rat Arhgdig (Rn01750774_m1); Rat Arhgef7 (β-pix)
(Rn00586980_m1); Rat Arhgef9 (Rn00576661_m1); Rat Fgd4 (Frabin) (Rn00594991_m1); Rat
Oligophrenin-1 (Rn01752886_m1); Rat Vav2 (Rn01436349_m1)
PCR reactions were run using a StepOnePlus Real-Time PCR System (Applied Biosystems,
USA) under the following thermocycler conditions of 95˚C for 10 min, 40 cycles of 95˚C for
30 sec, 58˚C for 1 min and 72˚C for 1 min. All samples were tested in triplicate and mean Ct
values were calculated for transcriptional changes by normalizing to a standard curve for the
housekeeping gene, human beta actin (Hs01060665 probe). No-template controls were also
included in each amplification run to monitor for contamination.
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Confocal imaging and analysis
Confocal images were acquired on a laser scanning Olympus Fluoview 1000 microscope (IX81
base) equipped with a 60X/1.35 NA oil objective (Olympus). Green fluorescent probes (GFP)
were excited with a 488 nm laser line of a multi-Argon laser, while red probes (Rhodamine)
were excited with the 543 nm laser line of a He-Ne laser; and the far-red probe Alexa647 was
excited with the 635 nm line of a diode laser. Fluorescence emission was collected using the
following dichroic mirror/filter combinations: SDM560/BA505-525 (GFP), SDM640/BA560-
620 (mCherry, RFP, Alexa568 and Rhodamine) and BA655-755 (Alexa647). Fluorescent
images were collected in a Z-stack and in sequential line scanning mode using Olympus Fluo-
view software. Image analysis was performed with Image J software on max intensity Z
projections.
Statistical analysis
Statistical analysis was performed using Sigma Plot 11.0. In each case, we first assessed whether
the data assumed a normalized distribution using the Shapiro-Wilk test and also if the two
data sets under comparison presented with equal variance. If the data assumed a normalized
distribution with equal variance, the t-test was used to assess statistical significance. However,
if the data failed to have either a normalized distribution or equal variance, we used a non-
parametric statistical analysis, the Mann-Whitney Rank Sum Test. We have indicated the test
used to determine statistical significance in each figure legend.
FRET imaging and analysis
Confocal images were acquired with a Fluoview 1000 microscope using a 60× 1.35 NA oil
objective (Olympus). For dual-emission ratio imaging of Raichu-Cdc42/Rac, we used the
458 nm line of a multi-Argon ion laser for CFP excitation and SDM510/BA480-495 (CFP)
and BA535-565 (YFP/FRET) filters for the collection of CFP and YFP fluorescence emission,
respectively. Ratiometric FRET images of max intensity Z projections of the acquired CFP and
YFP images were created using the Biosensor Processing Software 2.1 available from the Danu-
ser laboratory (University of Texas Southwestern, Dallas, TX). Image analysis of the resulting
FRET images was performed with Image J software.
Total Internal reflection microscopy (TIRF)
TIRF images were acquired with an Olympus inverted microscope (IX70) fitted with a Ludl
modular automation controller (Ludl Electronic Products, Hawthorne, NY) using an Olympus
60X/1.45NA oil Plan Apochromatic TIRFM objective and charge-coupled device (CCD) cam-
era (Retiga Exi, QImaging). CHO.K1 cells were plated on 2ug/ml fibronectin-coated glass
coverslips and imaged in HyClone CCM1 media (GE Healthcare) at 37˚C within ~1hour of
plating. Images were acquired with Metamorph Imaging Software (Molecular Devises, Sunny-
vale, CA). Green fluorescent probes (GFP) were excited with a 488 nm laser line of a multi-
Argon laser, while red probes were excited with a 561nm diode laser. Images were acquired
every 5 sec for a total of 10 min.
Supporting Information
S1 Fig. Validation of shRNAs expressed in REF-52 cells. Protein schematics are based on
information available from www.uniprot.org, and the corresponding region targeted by the
different shRNAs are depicted below the schematic. Note: We were unable to detect expres-
sion of either Fdg4 (Frabin) or Arhgdig (RhoGDI-γ) in either REF-52 or CHO.K1 cell lines.
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However, the two different shRNAs targeting FDG4 did not downregulate expression of the
other GEFs, either β-pix or Vav2, and both shRNAs similarly reduced spine length (Fig 2D),
and the involvement of Cdc42 regulation in spine length was further confirmed by a FRET
biosensor (Fig 2E). Arhgdig, which was upregulated during neuronal development similar to
Arhgdia (Fig 1B), similarly affected mature spine morphology (Fig 5).
(TIF)
S1 Video. Rac photoactivation promotes spine precursor formation. A DIV-14 primary rat
hippocampal neuron transfected with a genetically encoded photoactivatable Rac was exposed
to 458 nm light at the indicated region of photoactivation at t = 0 sec (continuous slow scan
speed for ~49 sec), and the resulting spine precursor formation was monitored by timelapse
confocal microscopy. The magenta reference image represents neuron morphology at the time
of photoactivation and is superimposed with GFP timelapse images before (t = -120 sec to 0
sec) and after photoactivation (t = 0 sec to 300 sec).
(AVI)
S2 Video. Adhesion maturation in a control CHO.K1 cell. A CHO.K1 cell transfected with
paxillin mCherry was plated on fibronectin and imaged by TIRF microscopy to visualize adhe-
sions. In the bottom right, a protrusion exhibits small nascent adhesions, some of which begin
to mature into focal adhesions. Each frame = 10 sec for a total of 10 min.
(AVI)
S3 Video. ARHGAP23 promotes adhesion maturation. A CHO.K1 cell transfected with pax-
illin mCherry and ARHGAP23-GFP was plated on fibronectin and imaged by TIRF micros-
copy to visualize adhesions. GAP23 results in elongated adhesions, particularly along the side
of the protrusion. Each frame = 10 sec for a total of 10 min.
(AVI)
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